Work

A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer

Year: 2026

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-26-0689

Authors: Scott T. Tagawa, Charlene Thomas, Abdul Baseet Arham, Aaron Holmes, Valentina Marulanda Corzo, Tobechukwu Okobi, Shankar Vallabhajosula, Vasilios Avlonitis, Sandra Huicochea Castellanos, Jones T. Nauseef, Elisabeth O’Dwyer, Maham Fatima, Peter Gregos, Sarah Yuan, Cora N. Sternberg, Ana Molina, David M. Nanus, Neil H. Bander, Joseph R. Osborne

Institutions: NewYork–Presbyterian Hospital, Weill Cornell Medicine, Cornell University, NewYork–Presbyterian Brooklyn Methodist Hospital

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, Weill Cornell Medical College

Award: G9000316619

OpenAlex ID: W7170087799

FWCI:

Cites: 2

Cited by:

Related to: